Fosamax and Pulmicort drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fosamax (alendronate sodium) and Pulmicort (budesonide). Common drug interactions include nausea among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Fosamax and Pulmicort. It is created by eHealthMe based on reports of 495 people who take the same drugs from the FDA, and is updated regularly.
What is Fosamax?
Fosamax has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 105,452 Fosamax users. Check the latest studies of Fosamax.
What is Pulmicort?
Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.
495 people who take Fosamax and Pulmicort together, and have interactions are studied.
What are the common drug interactions of Fosamax and Pulmicort, by gender? *
What are the common drug interactions of Fosamax and Pulmicort, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Fosamax and Pulmicort?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Fosamax and Pulmicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fosamax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pulmicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fosamax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pulmicort and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium and budesonide (the active ingredients of Fosamax and Pulmicort, respectively), and Fosamax and Pulmicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Coq and Krill Oil - now
- Drug interactions of Metoprolol Tartrate and Vagifem - now
- Drug interactions of Nucala and Azithromycin - now
- Could Arzerra cause Tremor? - a second ago
- Adderall 15 vs. Daytrana, side effect and effectiveness comparison - 7 seconds ago
- Could Zolpidem Tartrate cause Interstitial Lung Disease? - 7 seconds ago
- Could Leqembi cause Hypertension Aggravated? - 8 seconds ago
- Could Rinvoq cause Swallowing Difficulty? - 8 seconds ago
- Could Vytorin cause Neutrophil Count Decreased? - 8 seconds ago
- Could Cyclophosphamide cause C-Reactive Protein Increased? - 9 seconds ago